Showing 601 - 620 results of 26,842 for search '(( 50 ((ppm decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (we decrease)) ))', query time: 0.79s Refine Results
  1. 601
  2. 602
  3. 603
  4. 604
  5. 605

    Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells by Tadeja Kuret (5059433)

    Published 2018
    “…<div><p>Serum amyloid A (SAA) is a sensitive inflammatory marker rapidly increased in response to infection, injury or trauma during the acute phase. …”
  6. 606

    Oral Efficacy of Apigenin against Cutaneous Leishmaniasis: Involvement of Reactive Oxygen Species and Autophagy as a Mechanism of Action by Fernanda Fonseca-Silva (356488)

    Published 2016
    “…</p><p>Methodology/Principal Finding</p><p>Apigenin reduced the infection index in a dose-dependent manner, with IC<sub>50</sub> values of 4.3 μM and a selectivity index of 18.2. …”
  7. 607
  8. 608
  9. 609
  10. 610
  11. 611

    Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase by Safiatou T. Coulibaly (816058)

    Published 2015
    “…Importantly, a remarkable effect is also observed in treatments with the anticancer compound cytarabine (AraC), for which a 10,000 fold decrease in IC50 occurred. …”
  12. 612
  13. 613

    The peak energy of the fitted model function of the Ti Kβ spectra as a function of the instrumental broadening by C T Chantler (557430)

    Published 2013
    “…</strong> The peak energy of the fitted model function of the Ti Kβ spectra as a function of the instrumental broadening. The measured broadening of the spectrum of 1.24(4) eV and the asymmetry of the peak leads to a shift of peak position of 0.25 eV or 50 ppm.…”
  14. 614
  15. 615

    Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study by Shengnan Chen (3595319)

    Published 2022
    “…The secondary endpoints were all-cause death and the development of cardiovascular disease (CVD) events. We found that DKD patients have a higher risk to develop 50% eGFR decline endpoint (HR:2.30, 95%CI [1.48–3.58], <i>p</i> < 0.001) and KRT endpoint (HR:1.64, 95%CI [1.13–2.37], <i>p</i> < 0.05) than NDKD patients. …”
  16. 616

    The ATR IR signal decreases with decreasing dilutions of cells. by Allison L. Stelling (392086)

    Published 2013
    “…<p>Shown is a box plot for serial dilutions of a glioblastoma cell suspension. …”
  17. 617
  18. 618
  19. 619

    Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

    Published 2013
    “…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”
  20. 620